{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:58:59Z","timestamp":1767970739178,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Samsung Biomedical Research Institute"},{"name":"Southampton National Institute for Health Research Biomedical Research Centre"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.atherosclerosis.2013.09.009","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T02:05:06Z","timestamp":1380074706000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis"],"prefix":"10.1016","volume":"231","author":[{"given":"Ki-Chul","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1567-5688(11)70885-6","article-title":"HDL-C: role as a risk modifier","volume":"12","author":"Barter","year":"2011","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/hrt.2007.126326","article-title":"Time to rethink high-density lipoprotein?","volume":"94","author":"Wild","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jc.2010-0163","article-title":"Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease","volume":"96","author":"Brewer","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0021-9150(00)00528-1","article-title":"Coronary artery disease in patients at low risk \u2013 apolipoprotein AI as an independent risk factor","volume":"155","author":"Francis","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib8","doi-asserted-by":"crossref","first-page":"891403","DOI":"10.1155\/2013\/891403","article-title":"HDL, atherosclerosis, and emerging therapies","volume":"2013","author":"Hafiane","year":"2013","journal-title":"Cholesterol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.106.178458","volume":"114","author":"Budoff","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.amjcard.2010.03.018","article-title":"Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)","volume":"106","author":"Ridker","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1194\/jlr.M800622-JLR200","article-title":"Selective delipidation of plasma HDL\u00a0enhances reverse cholesterol transport in\u00a0vivo","volume":"50","author":"Sacks","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.ATV.0000022850.59845.E0","article-title":"Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I\/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction","volume":"22","author":"Luc","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2010.09.033","article-title":"Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance","volume":"107","author":"Martin","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2011.10.101","article-title":"Apolipoprotein A-I stimulates cholesteryl ester transfer protein and apolipoprotein E secretion from lipid-loaded macrophages; the role of NF-kappaB and PKA signaling pathways","volume":"415","author":"Niculescu","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib20","doi-asserted-by":"crossref","first-page":"e33917","DOI":"10.1371\/journal.pone.0033917","article-title":"Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts","volume":"7","author":"Cheng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.09.009_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0021-9150(01)00490-7","article-title":"Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport","volume":"159","author":"Zhang","year":"2001","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013005261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013005261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T18:57:45Z","timestamp":1539370665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013005261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0021915013005261"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}